NLS Pharmaceutics Ltd (NLSP)
1.50
+0.05
(+3.45%)
USD |
NASDAQ |
Apr 15, 16:00
1.38
-0.12
(-8.00%)
After-Hours: 20:00
NLS Pharmaceutics Max Drawdown (5Y)
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AC Immune SA | 89.55% |
| CRISPR Therapeutics AG | 83.80% |
| Addex Therapeutics Ltd | 98.94% |
| Molecular Partners AG | -- |
| Sophia Genetics SA | -- |